The pharmaceutical industry, key in the energy transition to achieve a sustainable future

In a world increasingly aware of the challenges of climate change and the need to reduce greenhouse gas emissions, major sectors must commit to sustainability. The pharmaceutical industry, being one of the most energy-intensive in the world, is no exception. It is crucial that this industry also adopts significant measures to contribute to the fight against climate change and reduce its carbon footprint. One of the strategies that would yield the best results in achieving greater sustainability in the pharmaceutical industry is photovoltaic self-consumption. This practice already allows companies in numerous sectors to produce their own electrical energy through solar panels, thereby reducing their electricity costs and increasing their energy independence. In this context, at Edison Next we present ourselves as a key ally to accompany the pharmaceutical sector in this process, providing innovative and efficient solutions for implementing photovoltaic self-consumption systems. Furthermore, the commitment to solar energy not only reduces electricity costs and increases energy independence but also contributes to reducing greenhouse gas emissions by using a renewable and clean energy source. On the other hand, energy efficiency also plays a crucial role in the pursuit of greater sustainability in the pharmaceutical industry. Optimizing production processes, installing more efficient equipment, and implementing energy management systems are measures that can help reduce energy consumption and, consequently, carbon emissions. In this regard, at Edison Next we have extensive experience in Building Management System (BMS) solutions, thanks to which our clients have been able to improve the energy management of their buildings and facilities for years. These systems allow for intelligent monitoring and control of energy use, automatically adjusting lighting, HVAC, and other systems to optimize energy consumption and achieve economic savings. With our help and our advanced energy management solutions, pharmaceutical companies can take another step towards sustainability by improving the efficiency of their facilities and reducing their environmental footprint. Additionally, Edison Next, in its role as the Delegate Subject of the Energy Savings Certificates system, offers a unique pathway for monetizing the energy savings achieved. In this way, pharmaceutical companies can not only reduce their energy consumption and carbon emissions but also generate economic value from these savings. Edison Next handles the entire process of certification and validation of energy savings, allowing companies to benefit from financial incentives and further contribute to their economic and environmental sustainability. This ability to convert energy savings into additional monetary resources makes collaboration with Edison Next a strategic choice for pharmaceutical companies seeking to optimize their energy and financial performance on the path to sustainability.